PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that the underwriters of its recently completed initial public offering of common stock have partially exercised their overallotment option and will purchase an additional 1,382,651 shares of common stock at the initial public offering price of $5.00 per share, less the underwriting discount. The sale of the additional shares is anticipated to close on December 28, 2010. Including proceeds from the sale of the additional shares, the gross proceeds, before expenses, from the initial public offering of a total of 13,382,651 shares of common stock and the concurrent private placement of 2,000,000 shares of common stock are approximately $76.9 million, and the net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses, are approximately $71.0 million.
